Enrolling Studies


Volunteer in a research study

Contact a Hope Clinic study recruiter

Monetary compensation for time and travel varies depending on the study

HIV Vaccine Trials Network

The purpose of this study is to look at how the immune system responds to an investigational HIV vaccine. Please contact Harlan Smith at harlan.smith@emory.edu or 404-712-8063 if interested in participating.

The Mosaico clinical trial is designed to test whether an HIV vaccine will work in preventing HIV infection in healthy individuals. The goal of this study is to evaluate the immune responses of 2 HIV vaccines in men and transgender individuals who have sex with men. Please contact Rameses Frederick at rameses.frederick@emory.edu or 404-712-9076 if interested in participating.

Mosaico Study Interest Form

Vaccine Trials Unit

Shingrix VAX2-007 This study is looking for healthy adults, 50-60 or 70+ who have not received either of the 2 Shingles vaccines and have not had the Shingles infection. This study is being done to investigate the response of the immune system to the new herpes zoster (shingles) vaccine.

To participate or for more information, please call Eileen Osinski at 404-712-1371 or send an email to gosinsk@emory.edu

Volunteer for a Rabies Vaccine Study.  Help us compare an existing rabies vaccine to a new study.

Eligibility: We are looking for healthy adults between the ages of 18-49 years of age.  The study duration lasts for 13 months and includes 1-2 screening visits, 4 vaccine visits, 6 follow up visits, 1 scheduled phone call and blood and urine samples.

Compensation: The study compensation is $75 per screening visit, $75 per vaccine visit, $50 per followup visit, $20 per scheduled phone call.

To participate or for more information, please call Brittany Robinson at 404-710-4007 or send an email to vaccine@emory.edu

A clinical trial research study investigating the yellow fever vaccine. Adults who have never had the yellow fever vaccine but are planning on getting the vaccine may be eligible to participate in the study. Participants need to be between the ages of 18-55 years of age, in generally good health and must have never received the yellow fever vaccine before.  Volunteers will be compensated for all study visits.  Compensation is $75 for a screening appointment and $75 for each follow-up appointment (3-7 visits). 

To participate or for more information, please email vaccine@emory.edu  or call 404-712-1371.

Sexual Health Studies

To participate or for more information about the following studies, please email us at hope.community@emory.edu or call at 877-288-0048

The purpose of this study seeks to understand the immune effects on the rectum of abstinence, frequent receptive anal intercourse (RAI) with a condom, and frequent RAI without a condom in adult men who have sex with men (MSM).

Eligibility: The population being studied for this protocol will be HIV negative men aged 18-49 years who have sex with an HIV negative man in a monogamous relationship for at least 45 days.

Compensation: Participants will receive $25 for completion of study visit 1 and $125 for completion of each follow-up study visit (3 visits).

Couples Study - FAQ

The purpose of this study is to understand how the immune system in the rectum of young men who have sex with men is altered by the presence of asymptomatic sexually transmitted infections (STI), specifically gonorrhea, chlamydia, and syphilis.

Eligibility: The population being studied for this protocol will be HIV negative or HIV positive YMSM between the ages of 18-29 years.

Compensation: Participants will receive $25 for completion of study visit 1 and $125 for completion of study visit 2.

The TRANSExplore Study aims to better understand the effect of feminizing hormones on the tissues that line the rectum. This study will begin enrolling soon. Transgender women, as well as cisgender men, will be eligible to participate.

The CFAR Repository Study aims to store a library of samples so they are available for researchers who need them. This study is looking for HIV-negative people of any gender to participate.

The purpose of this study is to collect blood and rectal biopsy specimens from HIV infected individuals, HIV negative at-risk individuals, or HIV negative low-risk individuals to better understand HIV transmission and/or disease.

We seek to determine if the rectums of persons who engage in receptive anal sex (aka-bottom) heal differently than those who do not.

We plan to recruit HIV-negative cisgender men.

The aim of this study is to better understand how biomarkers, such as those found in blood, urine, and hair, might be used to confirm self-reported adherence to event-driven PrEP or 2-1-1 PrEP.

We plan to enroll HIV-negative cisgender men who have sex with men not currently taking PrEP or PEP, and who reports having sex with another person assigned male sex at birth.

COVID-19 Studies

The Coronavirus Prevention Network is designed to develop the clinical and laboratory pipelines for the rapid implementation of COVID vaccine efficacy trials while conducting groundbreaking scientific investigations.

A clinical trial called CoVPN 5001 will help the newly formed COVID-19 Prevention Network (CoVPN) understand early SARS-CoV-2 infection and the body’s early immune responses to the virus that causes COVID-19 illness. CoVPN 5001 is designed to follow an estimated 800 study participants aged 18 years or older who have tested positive for SARS-CoV-2 infection.

Study participants will be enrolled into one of three groups: those showing no symptoms, those showing mild symptoms, and those showing severe symptoms that require hospitalization. Participants may move between groups if their symptoms worsen over the course of the study. Participation in this study will last for about a month with six visits followed by a health phone call one month after the last visit. Procedures will include one or more blood draw visits and collection of samples such as nasal swab, urine and optional stool samples. Compensation will be provided for time, inconvenience and travel.

A safe and effective vaccine is necessary to reduce morbidity and mortality and aid the global community to return to a thriving social and economic global infrastructure. CoVPN will work to develop and conduct studies to ensure a rapid and thorough evaluation of United States government-sponsored COVID-19 vaccines and antibodies for the prevention of COVID-19 disease.

Eligibility Criteria:

  • 18 years and older
  • Any gender or sexual orientation
  • Positive COVID-19 test within 6 days of enrollment

CoVPN 5001 Press Release: Harmonizing efforts to conduct large scale COVID-19 vaccine efficacy trials

CoVPN 5001 Study Fact Sheet

Please contact Rameses Frederick at rameses.frederick@emory.edu or 404-712-9076 if interested in participating. 

Volunteer for CoVPN 5001

This research study is looking at an experimental drug combination REGN10933 and REGN10987 monoclonal antibodies, given as separate subcutaneous (SC, under the skin) injections. The aim of the study is to see how safe, tolerable, and effective the study drugs may be in treating people who have been exposed to SARS CoV-2 by someone in your home and have tested negative virus and are not showing any signs of infection. A monoclonal antibody is a special kind of antibody that is made in a laboratory. Researchers can design these antibodies to fight specific types of infections, such as viruses.

Please contact Nipuni Gomes at nipuni.gomes@emory.edu or 470-586-4908 if interested in participating.

The purpose of the study is to look at how long and how strongly the immune system responds to COVID-19 infections. Individuals who have been diagnosed with COVID-19 would be eligible to enroll in this study. Participation in this study will consist of coming to the Hope Clinic to have your blood drawn 7 times over a 2-year period. Compensation will be provided for time and travel in the form of $50 for each clinic visit. Participants will not receive any vaccine or treatment during this study. 

Eligibility Criteria:

  • Proof of a confirmed positive test result within the last 60 days
  • Ages 18 years and above
  • HIV-negative

If interested & potentially eligible, please contact Rebecca Fineman at rebecca.fineman@emory.edu or 404-712-1158. 

Volunteer for the COVID Memory Study

The purpose of the study is to look at how the immune system responds to infections with emerging infectious diseases of public importance. This study will also determine if there are different or better tests that can be used to study these emerging infections.

For more information, please contact Rebecca Fineman at 404-712-1158 or rebecca.fineman@emory.edu

 Phlebotomy Emergent Study Interest Form

See more information regarding these studies on the COVID-19 page